Literature DB >> 1775635

Vitamin D3 stimulates the production of prostacyclin by vascular smooth muscle cells.

M Wakasugi1, T Noguchi, M Inoue, Y Kazama, M Tawata, Y Kanemaru, T Onaya.   

Abstract

The effects of vitamin D3 on the production of prostacyclin (PGI2) by cultured rabbit vascular smooth muscle cells (VSMCs) were investigated. PGI2 synthesis by VSMCs was significantly increased in the presence of 1,25-dihydroxyvitamin D3 (1,25(OH)2D3) and 1 alpha hydroxyvitamin D3 (1 alpha(OH)D3) at 48 hours [1,25(OH)2D3 greater than 1 alpha(OH)D3]. Physiological concentration of 1,25(OH)2D3 (10(-10) M) significantly increased the synthesis of PGI2. Further, we observed that treatment with 1,25(OH)2D3 significantly induced the activity of cyclooxygenase without changing the activity of phospholipase A2. These findings suggest that the mechanism of action of 1,25(OH)2D3 on the synthesis of PGI2 is mediated by the cyclooxygenase pathway. It seems possible that vitamin D3 is a vasoactive agent and may play a protective role in the development of atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1775635     DOI: 10.1016/0090-6980(91)90072-n

Source DB:  PubMed          Journal:  Prostaglandins        ISSN: 0090-6980


  19 in total

Review 1.  Should hypertensive patients take vitamin D?

Authors:  Gregoire Wuerzner; Michel Burnier; Bernard Waeber
Journal:  Curr Hypertens Rep       Date:  2012-08       Impact factor: 5.369

2.  Association between serum vitamin D levels and subclinical coronary atherosclerosis and plaque burden/composition in young adult population.

Authors:  Seckin Satilmis; Omer Celik; Ismail Biyik; Derya Ozturk; Kubra Celik; Fatih Akın; Burak Ayca; Burce Yalcin; Sinan Dagdelen
Journal:  Bosn J Basic Med Sci       Date:  2015-02-08       Impact factor: 3.363

3.  Vitamin D and Cardiovascular Disease: Can Novel Measures of Vitamin D Status Improve Risk Prediction and Address the Vitamin D Racial Paradox?

Authors:  Samuel M Kim; Pamela L Lutsey; Erin D Michos
Journal:  Curr Cardiovasc Risk Rep       Date:  2017-01-21

4.  Plasma 25-hydroxyvitamin D and regulation of the renin-angiotensin system in humans.

Authors:  John P Forman; Jonathan S Williams; Naomi D L Fisher
Journal:  Hypertension       Date:  2010-03-29       Impact factor: 10.190

5.  Effect of vitamin D receptor knockout on cornea epithelium wound healing and tight junctions.

Authors:  Rodolfo A Elizondo; Zhaohong Yin; Xiaowen Lu; Mitchell A Watsky
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-07-24       Impact factor: 4.799

6.  Vitamin D and Atherosclerotic Cardiovascular Disease.

Authors:  Thomas Hiemstra; Kenneth Lim; Ravi Thadhani; JoAnn E Manson
Journal:  J Clin Endocrinol Metab       Date:  2019-04-04       Impact factor: 5.958

7.  Effect of cholecalciferol on local arterial stiffness and endothelial dysfunction in children with chronic kidney disease.

Authors:  Mehmet Baha Aytaç; Murat Deveci; Kenan Bek; Özlem Kayabey; Zelal Ekinci
Journal:  Pediatr Nephrol       Date:  2015-10-02       Impact factor: 3.714

8.  Low vitamin D status in systemic sclerosis and the impact on disease phenotype.

Authors:  Laura Groseanu; Violeta Bojinca; Tania Gudu; Ioana Saulescu; Denisa Predeteanu; Andra Balanescu; Florian Berghea; Daniela Opris; Andreea Borangiu; Cosmin Constantinescu; Magda Negru; Ruxandra Ionescu
Journal:  Eur J Rheumatol       Date:  2016-02-01

9.  Vitamin d and cardiovascular disease.

Authors:  Jacqueline S Danik; Joann E Manson
Journal:  Curr Treat Options Cardiovasc Med       Date:  2012-08

10.  Serum vitamin D, parathyroid hormone levels, and carotid atherosclerosis.

Authors:  Jared P Reis; Denise von Mühlen; Erin D Michos; Edgar R Miller; Lawrence J Appel; Maria R Araneta; Elizabeth Barrett-Connor
Journal:  Atherosclerosis       Date:  2009-06-06       Impact factor: 5.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.